No Record Found
Sector
PharmaceuticalsOpen
₹334.3Prev. Close
₹332.65Turnover(Lac.)
₹430.38Day's High
₹334.55Day's Low
₹321.6552 Week's High
₹504.2552 Week's Low
₹298.8Book Value
₹61.16Face Value
₹1Mkt Cap (₹ Cr.)
3,248.15P/E
54.57EPS
6.1Divi. Yield
0.03No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 10.13 | 10.03 | 9.69 | 9.69 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 591.23 | 522.53 | 338.11 | 259.42 | 
| Net Worth | 601.36 | 532.56 | 347.8 | 269.11 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
| Revenue | 779.15 | 487.69 | 357.75 | 300.96 | 
| yoy growth (%) | 59.76 | 36.32 | 18.86 | 22.58 | 
| Raw materials | -411.96 | -250.29 | -177.47 | -142.22 | 
| As % of sales | 52.87 | 51.32 | 49.6 | 47.25 | 
| Employee costs | -85.61 | -66.21 | -51.57 | -44.46 | 
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
| Profit before tax | 126.83 | 57.71 | 30.33 | 27.95 | 
| Depreciation | -17.13 | -16.3 | -8.35 | -4.3 | 
| Tax paid | -30.99 | -13.47 | -7.47 | -13.51 | 
| Working capital | 30.22 | -13.96 | 33.14 | 35.94 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 59.76 | 36.32 | 18.86 | 22.58 | 
| Op profit growth | 73.63 | 88.23 | 16.83 | 66.26 | 
| EBIT growth | 84.57 | 65.73 | 16.98 | 77.7 | 
| Net profit growth | 116.67 | 93.51 | 42.66 | 77.6 | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | 
|---|---|---|
| Gross Sales | 819.81 | 806.67 | 
| Excise Duty | 0 | 0 | 
| Net Sales | 819.81 | 806.67 | 
| Other Operating Income | 0 | 0 | 
| Other Income | 3.63 | 2.18 | 
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,715.9 | 82.68 | 4,11,821.85 | 753.53 | 0.93 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,512 | 73.97 | 1,72,810.75 | 557 | 0.46 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,581.1 | 24.72 | 1,27,687.56 | 1,303.13 | 1.01 | 4,501.66 | 397.38 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,599.3 | 61.29 | 1,21,834.89 | 551 | 0.17 | 2,567 | 224.34 | 
| Dr Reddys Laboratories Ltd DRREDDY | 1,250.9 | 19.37 | 1,04,543.72 | 387.3 | 0.64 | 4,602.9 | 377.57 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Jayesh P Choksi
Whole Time Director & Chief Executive Officer
Pranav J Choksi
Whole-time Director
Pankaj Gandhi
Company Sec. & Compli. Officer
Ami Naresh Shah
Non Executive & Independent Director
Shrirang V Vadiya
Non-Executive & Non-Independent Director
Balram Singh
Non Executive & Independent Director
Rabi Narayan Sahoo
Non Executive & Independent Director
Anusanjiv Aurora
Whole-time Director
Dilip Ghosh
Non Executive & Independent Director
Kamal Kishore Seth
Additional Director
Akshya Kumar Mahapatra
Shop-37 1st Flr Kamala Bhavan,
Swami Nityanand Road Andheri(E,
Maharashtra - 400069
Tel: 91-022-66919187/67261007/66919189
Website: http://www.gufic.com
Email: corporaterelations@guficbio.com; mgr_legal@guficbi
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients. Renowned for its extensive range of pharma...
Read More
Reports by Gufic BioSciences Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.